Article
Las Vegas - The FDA on Jan. 2 cleared Berlex Laboratories Inc. to market Finacea (azelaic acid 15 percent) gel for the treatment of rosacea.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.